Attarwala H - Search Results

1

Oral nucleic acid therapy using multicompartmental delivery systems.

Attarwala H, Han M, Kim J, Amiji M. Attarwala H, et al. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018 Mar;10(2):10.1002/wnan.1478. doi: 10.1002/wnan.1478. Epub 2017 May 24. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018. PMID: 28544521 Free PMC article. Review.

2

Pharmacokinetics and Biodistribution Analysis of Small Interference RNA for Silencing Tissue Transglutaminase-2 in Celiac Disease After Oral Administration in Mice Using Gelatin-Based Multicompartmental Delivery Systems.

Attarwala HZ, Suri K, Amiji MM. Attarwala HZ, et al. Bioelectricity. 2020 Jun 1;2(2):167-174. doi: 10.1089/bioe.2020.0008. Epub 2020 Jun 17. Bioelectricity. 2020. PMID: 34471844 Free PMC article.

3

Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tract.

Kriegel C, Attarwala H, Amiji M. Kriegel C, et al. Among authors: attarwala h. Adv Drug Deliv Rev. 2013 Jun 15;65(6):891-901. doi: 10.1016/j.addr.2012.11.003. Epub 2012 Dec 7. Adv Drug Deliv Rev. 2013. PMID: 23220324 Review.

4

Co-Silencing of Tissue Transglutaminase-2 and Interleukin-15 Genes in a Celiac Disease Mimetic Mouse Model Using a Nanoparticle-in-Microsphere Oral System.

Attarwala HZ, Suri K, Amiji MM. Attarwala HZ, et al. Mol Pharm. 2021 Aug 2;18(8):3099-3107. doi: 10.1021/acs.molpharmaceut.1c00322. Epub 2021 Jul 6. Mol Pharm. 2021. PMID: 34228470

5

Multi-compartmental nanoparticles-in-emulsion formulation for macrophage-specific anti-inflammatory gene delivery.

Attarwala H, Amiji M. Attarwala H, et al. Pharm Res. 2012 Jun;29(6):1637-49. doi: 10.1007/s11095-012-0677-9. Epub 2012 Jan 27. Pharm Res. 2012. PMID: 22281760

6

Cosilencing Intestinal Transglutaminase-2 and Interleukin-15 Using Gelatin-Based Nanoparticles in an in Vitro Model of Celiac Disease.

Attarwala H, Clausen V, Chaturvedi P, Amiji MM. Attarwala H, et al. Mol Pharm. 2017 Sep 5;14(9):3036-3044. doi: 10.1021/acs.molpharmaceut.7b00233. Epub 2017 Aug 10. Mol Pharm. 2017. PMID: 28737923

7

Mathematical Modeling and Experimental Validation of Extracellular Vesicle-Mediated Tumor Suppressor MicroRNA Delivery and Propagation in Ovarian Cancer Cells.

Gandham SK, Attarwala HZ, Amiji MM. Gandham SK, et al. Among authors: attarwala hz. Mol Pharm. 2022 Nov 7;19(11):4067-4079. doi: 10.1021/acs.molpharmaceut.2c00525. Epub 2022 Oct 13. Mol Pharm. 2022. PMID: 36226722

8

Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc-siRNA conjugates.

Nair JK, Attarwala H, Sehgal A, Wang Q, Aluri K, Zhang X, Gao M, Liu J, Indrakanti R, Schofield S, Kretschmer P, Brown CR, Gupta S, Willoughby JLS, Boshar JA, Jadhav V, Charisse K, Zimmermann T, Fitzgerald K, Manoharan M, Rajeev KG, Akinc A, Hutabarat R, Maier MA. Nair JK, et al. Among authors: attarwala h. Nucleic Acids Res. 2017 Nov 2;45(19):10969-10977. doi: 10.1093/nar/gkx818. Nucleic Acids Res. 2017. PMID: 28981809 Free PMC article.

9

Role of antibodies in cancer targeting.

Attarwala H. Attarwala H. J Nat Sci Biol Med. 2010 Jul;1(1):53-6. doi: 10.4103/0976-9668.71675. J Nat Sci Biol Med. 2010. PMID: 22096337 Free PMC article.

10

Patisiran Pharmacokinetics, Pharmacodynamics, and Exposure-Response Analyses in the Phase 3 APOLLO Trial in Patients With Hereditary Transthyretin-Mediated (hATTR) Amyloidosis.

Zhang X, Goel V, Attarwala H, Sweetser MT, Clausen VA, Robbie GJ. Zhang X, et al. Among authors: attarwala h. J Clin Pharmacol. 2020 Jan;60(1):37-49. doi: 10.1002/jcph.1480. Epub 2019 Jul 19. J Clin Pharmacol. 2020. PMID: 31322739 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page